Beta Bionics shares slide after pricing underwritten public offering
Beta Bionics priced an underwritten public offering, and the stock fell 5.8% to $18.11 in premarket trading Wednesday after being down 37% for the year at Tuesday’s close.
Beta Bionics shares fell after the company priced its underwritten public offering. 11 in premarket trading on Wednesday. At Tuesday's market close, the shares were down 37% this year. 7 million shares.